{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CGON/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:00:59.498Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9093,"canonical_name":"CG Oncology, Inc.","cik":"0001991792","uei":null,"lei":null,"duns":null,"ticker":"CGON"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":55},"count":55,"timeline":[{"ts":"2026-09-21","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-09-21","url_slug":"/sec/cik-0001991792/144/0001950047-26-009691","accession_number":"0001950047-26-009691","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-09-17","url_slug":"/sec/cik-0001991792/144/0001950047-26-009639","accession_number":"0001950047-26-009639","importance":30},{"ts":"2026-09-11","kind":"sec.form144","reporter":"AMBAW BELLETE","title":"Officer","shares":826,"usd_value":61950,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001950047-26-009375","importance":40.01239},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-09-11","url_slug":"/sec/cik-0001991792/144/0001950047-26-009375","accession_number":"0001950047-26-009375","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-09-02","url_slug":"/sec/cik-0001991792/144/0001950047-26-009036","accession_number":"0001950047-26-009036","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-31","url_slug":"/sec/cik-0001991792/144/0001950047-26-008873","accession_number":"0001950047-26-008873","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-27","url_slug":"/sec/cik-0001991792/144/0001950047-26-008793","accession_number":"0001950047-26-008793","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-25","url_slug":"/sec/cik-0001991792/144/0001950047-26-008678","accession_number":"0001950047-26-008678","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-24","url_slug":"/sec/cik-0001991792/144/0001950047-26-008634","accession_number":"0001950047-26-008634","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-19","url_slug":"/sec/cik-0001991792/144/0001950047-26-008371","accession_number":"0001950047-26-008371","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-17","url_slug":"/sec/cik-0001991792/144/0001950047-26-008205","accession_number":"0001950047-26-008205","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-14","url_slug":"/sec/cik-0001991792/144/0001950047-26-008191","accession_number":"0001950047-26-008191","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-13","url_slug":"/sec/cik-0001991792/144/0001950047-26-008109","accession_number":"0001950047-26-008109","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CG Oncology, Inc. — 2026-08-13","url_slug":"/sec/cik-0001991792/schedule-13g-a/0000902219-26-000242","accession_number":"0000902219-26-000242","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-12","url_slug":"/sec/cik-0001991792/144/0001950047-26-008043","accession_number":"0001950047-26-008043","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"AMBAW BELLETE","title":"Officer","shares":50000,"usd_value":3810255,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007989","importance":40.762051},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-11","url_slug":"/sec/cik-0001991792/144/0001950047-26-007989","accession_number":"0001950047-26-007989","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-10","url_slug":"/sec/cik-0001991792/144/0001950047-26-007845","accession_number":"0001950047-26-007845","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-07","url_slug":"/sec/cik-0001991792/144/0001950047-26-007823","accession_number":"0001950047-26-007823","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CG Oncology, Inc. — 2026-08-06","url_slug":"/sec/cik-0001991792/10-q/0001193125-26-336918","accession_number":"0001193125-26-336918","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — CG Oncology, Inc. — 2026-08-06","url_slug":"/sec/cik-0001991792/8-k/0001193125-26-336886","accession_number":"0001193125-26-336886","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-06","url_slug":"/sec/cik-0001991792/144/0001950047-26-007736","accession_number":"0001950047-26-007736","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"424B5","title":"424B5 — CG Oncology, Inc. — 2026-08-06","url_slug":"/sec/cik-0001991792/424b5/0001193125-26-336792","accession_number":"0001193125-26-336792","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-08-05","url_slug":"/sec/cik-0001991792/144/0001950047-26-007711","accession_number":"0001950047-26-007711","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-07-29","url_slug":"/sec/cik-0001991792/144/0001950047-26-007416","accession_number":"0001950047-26-007416","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-07-28","url_slug":"/sec/cik-0001991792/144/0001950047-26-007370","accession_number":"0001950047-26-007370","importance":30},{"ts":"2026-07-27","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-07-27","url_slug":"/sec/cik-0001991792/144/0001950047-26-007310","accession_number":"0001950047-26-007310","importance":30},{"ts":"2026-07-27","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CG Oncology, Inc. — 2026-07-27","url_slug":"/sec/cik-0001991792/schedule-13g-a/0002012383-26-002283","accession_number":"0002012383-26-002283","importance":30},{"ts":"2026-07-23","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-07-23","url_slug":"/sec/cik-0001991792/144/0001950047-26-007270","accession_number":"0001950047-26-007270","importance":30},{"ts":"2026-07-15","kind":"sec.form144","reporter":"AMBAW BELLETE","title":"Officer","shares":52438,"usd_value":3816008,"security_title":"Common","approx_sale_date":"2026-07-15","accession_number":"0001950047-26-007109","importance":40.76320153},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"POST LEONARD E","title":null,"shares":1000,"price_per_share":71.17,"usd_value":71170,"security_title":"Common Stock","importance":35.07117},{"ts":"2026-07-15","kind":"sec.filing","form_type":"144","title":"144 — CG Oncology, Inc. — 2026-07-15","url_slug":"/sec/cik-0001991792/144/0001950047-26-007109","accession_number":"0001950047-26-007109","importance":30},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"POST LEONARD E","title":null,"shares":1000,"price_per_share":0.6,"usd_value":600,"security_title":"Common Stock","importance":15.0006},{"ts":"2026-07-10","kind":"sec.insider.s","reporter":"Mulay James","title":null,"shares":24165,"price_per_share":75.16,"usd_value":1816241,"security_title":"Common Stock","importance":36.8162414},{"ts":"2026-07-10","kind":"sec.insider.m","reporter":"Mulay James","title":null,"shares":24165,"price_per_share":26.63,"usd_value":643514,"security_title":"Common Stock","importance":15.64351395},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Mulay James — 2026-07-01","url_slug":"/sec/cik-0001684531/144/0001950047-26-006790","accession_number":"0001950047-26-006790","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — CG Oncology, Inc. — 2026-06-29","url_slug":"/sec/cik-0001991792/4/0001140361-26-026779","accession_number":"0001140361-26-026779","importance":30},{"ts":"2026-06-25","kind":"sec.insider.p","reporter":"Liu Brian Guan-Chyun","title":null,"shares":371085,"price_per_share":66.87,"usd_value":24814454,"security_title":"Common Stock","importance":74.81445395},{"ts":"2026-06-24","kind":"sec.form144","reporter":"LEONARD POST","title":"Director","shares":5000,"usd_value":328650,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006467","importance":40.06573},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"POST LEONARD E","title":null,"shares":5000,"price_per_share":70,"usd_value":350000,"security_title":"Common Stock","importance":35.35},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"POST LEONARD E","title":null,"shares":5000,"price_per_share":0.6,"usd_value":3000,"security_title":"Common Stock","importance":15.003},{"ts":"2026-06-22","kind":"sec.form144","reporter":"LEONARD POST","title":"Director","shares":6000,"usd_value":366480,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006393","importance":40.073296},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"POST LEONARD E","title":null,"shares":5000,"price_per_share":65,"usd_value":325000,"security_title":"Common Stock","importance":35.325},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"POST LEONARD E","title":null,"shares":5000,"price_per_share":0.6,"usd_value":3000,"security_title":"Common Stock","importance":15.003},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Mulay James","title":"","shares":1310,"price_per_share":60.12,"usd_value":78757,"security_title":"Common Stock","importance":35.0787572},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Mulay James","title":"","shares":654,"price_per_share":60.12,"usd_value":39318,"security_title":"Common Stock","importance":35.03931848},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Mulay James","title":"","shares":1310,"price_per_share":12.59,"usd_value":16493,"security_title":"Common Stock","importance":15.0164929},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Mulay James","title":"","shares":654,"price_per_share":3.72,"usd_value":2433,"security_title":"Common Stock","importance":15.00243288},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — CG Oncology, Inc. — 2026-06-08","url_slug":"/sec/cik-0001991792/8-k/0001193125-26-261670","accession_number":"0001193125-26-261670","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Mulay James — 2026-06-05","url_slug":"/sec/cik-0001684531/4/0001193125-26-259691","accession_number":"0001193125-26-259691","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — CG Oncology, Inc. — 2026-06-05","url_slug":"/sec/cik-0001991792/4/0001193125-26-259693","accession_number":"0001193125-26-259693","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — CG Oncology, Inc. — 2026-06-05","url_slug":"/sec/cik-0001991792/4/0001193125-26-259700","accession_number":"0001193125-26-259700","importance":30},{"ts":"2026-06-04","kind":"sec.form144","reporter":"LEONARD E POST","title":"Director","shares":3000,"usd_value":163260,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005645","importance":40.032652},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"POST LEONARD E","title":null,"shares":1000,"price_per_share":54.5,"usd_value":54500,"security_title":"Common Stock","importance":35.0545},{"ts":"2026-06-04","kind":"sec.insider.m","reporter":"POST LEONARD E","title":null,"shares":1000,"price_per_share":0.6,"usd_value":600,"security_title":"Common Stock","importance":15.0006}]}